ea0075t12 | Thyroid | EYES2021
Silva Eugenia
, Costa Ferreira Rute
, Ferrinho Catia
, Sousa Santos Francisco
, Gouveia Clotilde
, Oliveira Manuela
, Duarte Sequeira
Background: Agranulocytosis is rare and may develop in 0.20.5% patients using antithyroid drug therapy (ATD). We report on a patient who developed febrile neutropenia two weeks after starting treatment with methimazole.Case Report: A 74-year-old female, with no relevant medical history, was diagnosed with Graves disease and treated with methimazole (30 mg/day). Three weeks after starting therapy she presented to the emergency department with compla...